Ricevi le ultime notizie sulle azioni Hims & Hers Health con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di HIMS

Ultime notizie per

HIMS & HERS HEALTH INC

Hims & Hers Health

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Siegen,,North,Rhine,Westphalia,,,Germany,-,10,11,2023:

News

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Titolo in forte calo con nuove previsioni al ribasso: analisi tecnica e scenari possibili in un mercato farmaceutico in evoluzione.

Crollo storico per Novo Nordisk: quale futuro dopo la revisione delle guidance?

Wegovy

Health Care

I giganti farmaceutici celebrano ricavi record. Ma un&#39;insidia nel comportamento dei pazienti minaccia la crescita a lungo termine.

Farmaci anti-obesità: vendite da record, ma c&#39;è un problema

Pharmacy,,Pills,And,Box,With,Healthcare,Store,,Shelf,And,Prescription

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

ARDT

CLOV

Tre titoli del settore sanitario che mostrano segnali di ipercomprato: è il momento di cavalcare il rialzo o prepararsi a un&#39;inversione?

Sanità: cavalcare l&#39;onda o prepararsi al tonfo? 3 titoli da monitorare

Hims & Hers Health Inc

Legal

Press Releases

DEADLINE ALERT for HIMS, IRBT, and CNC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

HIMS FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the August 25th Deadline for the Hims Lawsuit and Urges Investors to Contact The Firm

Hims & Hers Health, Inc. Class Action: Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 – HIMS

HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is Investigating Hims & Hers Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Hims Launches New Category in Men's Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties

Kuehn Law Encourages Investors of Hims & Hers Health, Inc. to Contact Law Firm

IRBT

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna Group

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Fresenius Medical Care

Guardant Health

Hinge Health

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Gr

Labcorp Hldgs

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

NeoGenomics

Omada Health

Option Care Health

OPKO Health

Premier

Pennant Gr

Privia Health Gr

RadNet

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Holdings

Canaccord Genuity

Truist Securities

Morgan Stanley

Piper Sandler

Citigroup

Stock,Market,And,Business,Activity,In,Asia.,Corporate,Value,And

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Emerging Markets

TSLA

LikeFolio&#39;s Watchlist (7 Stocks And 1 Crypto) During This Market Pullback

Screenshot 2024-09-04 at 5.36.44 PM

Biotech

General

MGRX

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Screenshot 2024-07-09 at 1.59.17 PM

Erectile Function Vs Erectile Dysfunction: How MangoRx&#39;s (NASDAQ: MGRX) Product Sets Itself Apart And Caters To A Large Market (Pun Intended)

Comments

Hims & Hers Health Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO